Celldex Therapeutics, Inc.
Leadership moves, last update 1 month ago
Pharma biotech · Headquarters United States
Everything we hold on Celldex Therapeutics, Inc., newest first. Every line links to the filing or report it came from.
- 2026-07-15Headcount Not Stated Leadership moves
Celldex Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
Celldex Therapeutics seeks a new CFO in Hampton, New Jersey, as Sam Martin plans to retire in March 2027.
- 2026-06-26Pay Change Leadership moves
Celldex Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
Celldex Therapeutics adjusts equity incentives in New Jersey, affecting compensation structures without disclosing specific hiring or role impacts.
- 2025-12-31Pay Change Pay and benefits
Celldex Therapeutics, Inc.: $5,366,709 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
Celldex Therapeutics, Inc.: $9,229,165 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
Celldex Therapeutics, Inc.: $8,361,844 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
Celldex Therapeutics, Inc.: $5,401,283 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Celldex Therapeutics, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/celldex-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker